The United States Food and Drug Administration (FDA) faces increasing pressure to enhance oversight over online prescription drug advertisements, as the popularity of social media influencers soars, raising worries about misinformation reaching susceptible patients and easily influenced teens. This growing concern has resulted in calls from people within the medical community and Congress for new FDA guidance and stricter enforcement. It is suggested that companies regulated by the FDA should contemplate revisiting their policies and practices pertaining to the influencers they associate with, according to legal professionals in the field. Visit here for detailed coverage.
Mahnu Davar, a partner at Arnold & Porter Kaye Scholer, exclaimed the need for more clarity from the FDA on its stance regarding its authority over social media. The growth of social media platforms has resulted in a boom in digital drug promotions, and there is a clear need for a more defined framework of guidelines and enforcement from regulatory authorities. The industry, it appears, is keen to understand more accurately the FDA’s position on this matter. Find out more here.